A central event in the development of the allergic response is the interaction between immunoglobulin E (IgE) and its cellular high-affinity receptor FcεRI. Allergen-bound IgE mediates the allergic response by binding through its Fc region to its cellular receptor on mast cells and basophils, causing the release of chemical mediators. One strategy for the treatment of allergic disorders is the use of therapeutic compounds which would inhibit the interaction between IgE and FcεRI. Using a structure-based design approach, conformationally constrained synthetic peptides were designed to mimic a biologically active β-hairpin region of the α-chain of FcεRI. Two peptide mimics of the FcεRI α-chain were previously shown to inhibit IgE- FcεRI interactions, one a peptide comprised of L-amino acids, covalently cyclized by N- and C-terminal cysteine residues, and the other its retroenantiomer. In this paper the solution structures of these compounds are derived using NMR spectroscopy. The topochemical relationship between the retroenantiomeric compounds and the structural basis of their biological activity is described.
ASJC Scopus subject areas
- Colloid and Surface Chemistry